Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Quantum Biopharma Ltd. (QNTM) had Return on Tangible Equity of -172.83% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-3.25M |
|
-- |
|
-- |
|
$2.29M |
|
$-2.29M |
|
$-0.80M |
|
$-3.09M |
|
$-3.04M |
|
$-3.09M |
|
$-3.09M |
|
$-3.09M |
|
$-3.04M |
|
$-2.29M |
|
$-2.17M |
|
6.65M |
|
6.65M |
|
$-0.47 |
|
$-0.47 |
|
| Balance Sheet Financials | |
$9.96M |
|
$0.06M |
|
$4.43M |
|
$14.39M |
|
$8.30M |
|
-- |
|
-- |
|
$8.30M |
|
$6.09M |
|
$1.79M |
|
$6.09M |
|
7.58M |
|
| Cash Flow Statement Financials | |
$-3.46M |
|
$-4.26M |
|
$9.46M |
|
$1.91M |
|
$3.65M |
|
$1.74M |
|
$0.91M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.20 |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.46M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-50.75% |
|
|
Return on Tangible Equity |
-172.83% |
-21.49% |
|
-50.75% |
|
$0.80 |
|
$-0.52 |
|
$-0.52 |
|